Riverton, NJ, United States of America

Christopher William Schultz

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher William Schultz: Innovator in Cancer Treatment

Introduction

Christopher William Schultz is an accomplished inventor based in Riverton, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent work. His dedication to improving patient outcomes is evident in his groundbreaking inventions.

Latest Patents

Christopher Schultz holds a patent for "Methods of treating, ameliorating, and/or preventing cancer using pyrvinium compositions." This patent describes compositions of pyrvinium salts suitable for oral administration. These compositions are in the form of solutions and demonstrate bioavailability both in blood plasma and in pancreatic tissue. The patent also outlines methods for treating, ameliorating, and preventing pancreatic cancer, including the oral administration of a composition comprising pyrvinium pamoate. He has 1 patent to his name.

Career Highlights

Christopher Schultz is affiliated with Thomas Jefferson University, where he conducts his research and develops his innovative treatments. His work is focused on finding effective solutions for cancer patients, particularly those suffering from pancreatic cancer. His research has the potential to change the landscape of cancer treatment.

Collaborations

One of his notable collaborators is Jonathan R Brody, with whom he has worked closely on various projects related to cancer research and treatment.

Conclusion

Christopher William Schultz is a dedicated inventor whose work in cancer treatment showcases his commitment to advancing medical science. His innovative approaches and patented methods hold promise for improving the lives of cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…